Contents Previous Next

References: Chapters 13 to 15

  1. Adelman, E. M., & Thornton, S. R. (1983). Cardiac crisis: Are you sure you know what to do? RN, 46(8), 23.

  2. American medical association standards and guidelines for car-diopulmonary resuscitation and emergency cardiac care. (1980). Journal of the American Medical Association, 244, 453.

  3. Antman, E., Muller, ]., Goldberg, S., et al. (1980). Nifedipine therapy for coronary artery spasm. New England Journal of Medicine, 302. 1269.

  4. Awan, J. (1982). Cardiovascular action of Trimazosin. Clinical Pharmacology Therapeutics, 31(3), 290.

  5. Befeler, B., & Lazzara, R. (1980). Clinical pharmacology of the anti-arrhythmic agent disoprymide (norpace). Heart & Lung, 9, 746.

  6. Benotti, J. (1978). Hemodynamic assessment of amrenoril, a new inotropic agent. New England Journal of Medicine, 299, 1373.

  7. Bexton, R. S., Camm, A. J., Nathan, M. B., et al. (1984). Fatal ventricular tachycardias in association with propafenone, a new class Ic antiarrhythmic agent. Postgraduate Medical Journal, 60, 155. (From Department of Cardiology, St. Bartholomew Hospital, London.)

  8. Binnion, P. F. (1978). Drug interactions with digitalis glycosides. Drugs, 15, 369.

  9. Blaschke, T. F., and Melmon, K. L. (1980). Antihypertensive agents and the drug therapy of hypertension. In A. S. Gilman, L. S. Goodman, & A. Gilman (Eds.), The pharmacological basis of therapeutics, p. 805. New York: MacMillan.

  10. Borak, J., and Veilleux, S. (1982). Prophylactic lidocaine: Uncertain benefits in emergency settings. Annals of Emergency Medicine, 11, 493.

  11. Bravo, E. L. (1983). Effects of clonidine on sympathetic function. Chest, 83(2), 369.

  12. Budassi, S. (1981). Symposium on emergency nursing management of cardiopulmonary arrest. Nursing Clinics of North America, 16, 37.

  13. Bullas, J. B., and Talmadge, E. K. (1983). Thrombolytic therapy in acute evolving myocardial infarction. Critical Care Nurse, 3(4), 34.

  14. Buthler, V. P. Jr., & Lindenbaum, J. (1975). Serum digitalis measurements in the assessment of digitalis resistance and sensitivity. American Journal of Medicine, 58, 460.

  15. Campese, V. M., Stein, D., & Deguattr, V. (1979). Treatment of severe hypertension with minoxidil: Advantages and limitations. Journal of Clinical Pharmacology, 19, 231.

  16. Cantwell, R., Hollis, R., & Rodgers, M. (1982). Think fast: What do you know about drugs for a code? Nursing '82, 22(10), 34.

  17. Carlsen, J. E., & Svendsen, T. L. (1981). Immediate central and peripheral haemodynamic effects of a new vasodilatmg agent: Pinacidil, in hypertensive man. Clinical Physiology, 1, 375.

  18. Castellanos, A. (1980). Cardiac arrhythmias: Mechanisms and management. Philadelphia: F. A. Davis.

  19. Cavanaugh, A. L., & Mancini, R. E. (1980). Drug interactions and digitalis toxicity. American Journal of Nursing, 80, 2170.

  20. Chrysant, S. (1980). Systemic and renal hemodynamics effects of trimazosin. Journal of Cardiovascular Pharmacology, 2, 205.

  21. dark, J. B., Quenner, S. F., & Karb, V. B. (1982). Pharmacological basis of nursing practice. St. Louis: C. V. Mosby.

  22. Clark, R. (1979). Nifedipine: A myocardial protective agent [symposium]. American Journal of Cardiology, 44, 825.

  23. Coma-Canella I., Lopzz-Sendon, ]., Jaorague, L. M. (1984). Prenalterol in cardiogenic shock following acute MI. American Heart Journal, 107, 1195.

  24. Cridland, B., & Hawrocki, H. (1981). Giving cardiac care. Horsham: Intermed Communications.

  25. Crumpley, L., & Rinkenberger, R. L. (1983). An overview of antiarrhythmic drugs. Critical Care Nurse, 3(4), 57.

  26. Dangman, K. H. (1984). Cardiac effects of cibenzoline. Journal of Cardiovascular Pharmacology, 6, 300.

  27. Elliot, H. L., Meredith, P. A., Sumner, D. J. et al. (1982). A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin, in normotensive subjects. British Journal of Clinical Pharmacology, 13, 699.

  28. Ferguson, J. (1982). Effects of enalapril, a new converting enzyme inhibitor in hypertension. Journal of Clinical Pharmacology, 33, 48.

  29. Fishman, W. H. (1982). Beta adrenergic blockage in clinical practice. Hospital Practice, 17, 57.

  30. Fishman, W. H. (1982). Drug therapy: Atenolol and timolol, two new systemic beta adrenoceptor antagonists. New England Journal of Medicine, 306, 1456.

  31. Fouad, F. M., (1984). Clinical and systemic hemodynamic effects of nitroendipine. Clinical Pharmacology Therapeutics, 35(6), 768.

  32. Freeman, B., Dunn, R., Richmond, D., et al. (1981). Coronary artery spasm during exercise: Treatment with verapamil. Circulation, 64, 68.

  33. Fuller, E. 0. (1980). The effect of antianginal drugs on myocardial oxygen consumption. American Journal of Nursing, 80, 250.

  34. Gahart, B. L. (1985). Intravenous medications: A handbook of nurses and other allied health personnel (4th ed.). St. Louis: C. V. Mosby.

  35. Gever, L. (1984). Anticoagulants: What to teach your patient about them. Nursing '84, 14(11), 64.

  36. Gilman, A. G., Goodman, S. L., & Gilman, A. (Eds.). (1980). The pharmacological basis of therapeutics (6th ed.). New York: MacMillan.

  37. Grayboys, T. B. (1970). Clinical pharmacology of antiarrhythmic agents. Heart & Lung, 8, 706.

  38. Guthrie, G. P., Jr., Kotchen, T. A., & Hammond, J. A. (1983). Effects of treatment with and withdrawal from enalapril in essential hypertension. American Heart Association publication.

  39. Hager, W. D. (1979). Digoxin-quinidine interaction. New England Journal of Medicine, 300, 1238.

  40. Henry, P. (1979). Effect of nifedipine on myocardial ischemia: Analysis of collateral flow, pulsatile heat, and regional muscle shortening [symposium]. American Journal of Cardiology, 44, 708.

  41. Henry, P. D. (1980). Comparative pharmacology of calcium antagonists: Nifedipine, verapamil, and diltiazem. The American Journal of Cardiology, 46, 1047.

  42. Higuchi, M., Uetzels, E. (1980). Evaluation of long-term treatment of essential hypertension with quantacine. British Journal of Clinical Pharmacology, 10, 615.

  43. Hummelgard, A., & Esrig, B. (1981). Calcium and calcium slow channel blockers: An overview. Critical Care Quarterly, 4(2), 17.

  44. Hutton, I. et al. (1980). Haemodynamic effects of prenalteral in patients with coronary artery disease. British Heart Journal, 43, 134.

  45. Immis, A. D., & Jewitt, D. E. (1985). Studies with felodipine in CHF [supplement 2]. Drugs, 29, 66.

  46. Johnson, G. P., & Johanson, B. C. (1983). Beta blockers. American Journal of Nursing, 83, 1034.

  47. Kaltenback, M., Schulz, W., & Kober, G. (1979). Effects of nifedipine after intravenous intracoronary administration. American Journal of Cardiology, 44, 832.

  48. Kaplan, N. (1986). Clinical Hypertension (4th ed.). Baltimore: Williams & Wilkins.

  49. Kass, R. S. (1982). Nisoldipine, a new, more selective calcium current blocker in cardiac purkinje fibers. Journal of Pharmacology and Experimental Therapeutics, 223(2), 446.

  50. Keefe, D. L., Kates, R. E., & Harrison, D. C. (1981). New antiarrhythmic drugs: Their place in therapy. Drugs, 22, 363.

  51. Kelly, K. (1980). CPR—to certify or not to certify. Supervisor Nurse, 11,34.

  52. Kendall, M. ]., & John, V. A. (1983). Oxprenolol: Clinical pharmacology, pharmacokinetics, and pharmacodynamics. American Journal of Cardiology, 52, 270.

  53. Kleehammer, B. S., & Henson, B. (1983). Intracoronary strep-tokinase: Direct attack on acute MI. RN, 46 (12), 26.

  54. Koch-Weser, J. (1970). Drug therapy: Bretylium. New England Journal of Medicine, 300, 474.

  55. Kushner, M., Magiros, E., Peters, R., et al. (1984). The electro-physiologic effects of oral cibenzoline. Journal of Electrocar-diology, 17(1), 15.

  56. Leonard, R. G., & Talbert, R. L. (1982). Calcium channel blocking agents. Clinical Pharmacy, 1, 17.

  57. Loebl, S., Spratto, G., & Wit, A. (1980). The nurse's drug book (2nd ed.). New York: John Wiley.

  58. Lopez, L., & Mehta, J. (1984). Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension. American Journal of Cardiology, 53, 787.

  59. Lute, E. (1984). Calcium blockers: The important differences. RN, 47(6), 36.

  60. Mishkin, B., Holloran, S., & Burge, S. (1982). Stimulated cardi-opulmonary arrests in a hospital setting. Nurse Educator, 7, 13.

  61. Mitchell, L. (1982). Comparative clinical electrophysiologic effects of diltiazem, verapamil, and nifedipine: A review. American Journal of Cardiology, 49, 629.

  62. Monico, L. (1983). The role nurses play during a code. Nursing '83, 13(8), 34.

  63. Moskouitz, R. M., & Cohn, J. N. (1980). Hemodynamic effects of oxdralazine and hydralazine in hypertension. Clinical Pharmacology and Therapeutics, 27(6), 773.

  64. Muller, J., Gunther, S. (1978). Therapy for Prinzmetal's angina. Circulation, 57, 137.

  65. Nademanse, K. (1983). Amiodarone in refractory life-threatening ventricular arrhythmias. Annals of Internal medicine, 98, 577.

  66. Nademanse, K., & Singh, B. N. (1982). The role of newer antiarrhythmic drugs. JAMA, 247(2), 217.

  67. Needleman, P., & Johnson, E. M. (1980). Vasodilators and the treatment of angina. In A. G. Gilman, S. L. Goodman, & A. Gilman (Eds.), The pharmacological basis of therapeutics (6th ed.), p. 820. New York: MacMillan.

  68. Nissen, M. B. (1984). Streptokinase therapy in acute myocardial infarction. Heart &Lung, 13, 223.

  69. Noguchi, K. (1983). Effects of trapidil on forearm veins and arteries in man. Journal of Cardiovascular Pharmacology, 5, 768.

  70. Nurse's Reference Library. (1982). Drugs. Springhouse: In-termed Communications.

  71. Orlando, J. R., Danahy, D. T., & Lurie, M., et al. (1978). Trimazosin effect on hemodynamics in congestive heart failure. Clinical Pharmacology Therapeutics, 24, 531.

  72. Parrillo, J. E. (1983). Vasodilator therapy. In B. Chenow (Ed.), The pharmacologic approach to the critically ill patient (p. 283). Baltimore: Williams & Wilkins.

  73. Physician's Desk Reference: RN Edition. (1985). Oradell: Medical Economics Books.

  74. Purin-Parkinson, C. (1979). Sorting the adrenergic cholinergic drugs. RN, 42(7), 52.

  75. Quyyumi, A. A., Wagstaff, D., & Evans, T. R. (1983). Acute hemodynamic effects of endralazine: A new vasodilator for chronic refractory congestive heart failure. American Journal of Cardiology, 51, 1353.

  76. Reid, J. L., Meredith, P. A., Elliott, H. L. (1983). Pharmacokinetics and pharmacodynamics of trimazosin in man. American Heart Journal, 106, 1222.

  77. Rice, V. (1982). Calcium, the heart, and calcium antagonists. Critical Care Nurse, 1, 30.

  78. Romankiewicz, J. A., Brogden, R. H., Heel, R. C., et al. (1983). Captopril: An update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs, 25, 6.

  79. Rossi, L. P., & Antman, E. M. (1983). Calcium channel blockers: New treatment for cardiovascular disease. American Journal of Nursing, 33. 382.

  80. Sagar, D. P., & Bomar, S. K. (1980). Intravenous medications. Philadelphia: J. B. Lippincott.

  81. Schoetensack, W. (1983). Urapidil. In A. Scriabine (Ed.), New drugs annual: Cardiovascular drugs, p. 19. New York: Raven Press.

  82. Serruys, P. W., et al. (1983). Acute hemodynamic effects of nisoldipine in patients with CAD. American Heart Association publication.

  83. Shearer, ]., & Caldwell, M. (1979). Use of sodium nitroprus-side and dopamine hydrochloride in the postoperative cardiac patient. Heart & Lung, 8, 302.

  84. Simoneau,}., & Pura, L. (1978). The critical care nurse's role in resuscitation. Critical Care Quarterly, 1, 79.

  85. Sobel, B. E. (1981). Mechanisms of action and clinical implications of calcium antagonists. Practical Cardiology, 7, 31.

  86. Stanford, J. L., Felner, J. M., & Arensberg, D. (1980). Antiar-rhythmic drug therapy. American Journal of Nursing, 80, 1288.

  87. Ventura, H. 0., Messzali, F. H., Orgman, W., et al. (1983). Immediate hemodynamic effects of a new caldun-i channel blocking agent (nitrendipine) in essential hypertension. American Journal of Cardiology, 51, 783.

  88. Viachakis, N. D., Mendlowitz, M., & DeGuzzman, D. (1975). Treatment of essential hypertension with trimazosin, a new vasodilator agent. Curr Ther Res, 17, 564.

  89. Wilhemsen, L. (1978, May). Beta blockers and sudden death following MI. Cardiovascular Medicine, 557.

  90. Wilkins, L. H., Dustan, H. P., Walker, F., et al. (1983). Enalapril in low-renin essential hypertension. Clinical Pharmacology and Therapeutics, 34(3), 297.

  91. Woodbery, P., & Hamrie, A. (1981). Prepare your unit to manage a code with a mock emergency. Nursing '81, 11, 32.

  92. Wyman, M. G., & Gare, S. (1983). Lidocaine prophylaxis in myocardial infarction: A concept whose time has come [Editorial]. Heart & Lung, 12, 358.

  93. Zells, R. F. (1981). Calcium entry blockers in cardiologic therapy. Hospital Practice, 16, 49.